Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)
European Journal of Cancer2017Vol. 84, pp. 212–218
Citations Over TimeTop 10% of 2017 papers
Frédéric Bigot, Eduardo Castañón, Capucine Baldini, Antoine Hollebecque, Alberto Carmona‐Bayonas, Sophie Postel‐Vinay, Eric Angevin, Jean‐Pierre Armand, Vincent Ribrag, Sandrine Aspeslagh, Andréa Varga, Rastislav Bahleda, Jessica Menis, Anas Gazzah, Jean‐Marie Michot, Aurélien Marabelle, Jean‐Charles Soria, Christophe Massard
Related Papers
- → Impact of Margin Status and Local Recurrence on Soft-Tissue Sarcoma Outcomes(2013)76 cited
- → Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas(2019)20 cited
- → Association between GFR Estimated by Multiple Methods at Dialysis Commencement and Patient Survival(2013)12 cited
- → Temporal Variation in the Prognosis and Treatment of Advanced Heart Failure - Before and After 2000(2014)11 cited
- → Crude and adjusted hazard ratios of Cox proportional hazard regressions and 95% confidence interval for death during the follow-up period for study cohort.(2015)